179 related articles for article (PubMed ID: 18789902)
1. Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors.
Gelmedin V; Caballero-Gamiz R; Brehm K
Biochem Pharmacol; 2008 Oct; 76(9):1068-81. PubMed ID: 18789902
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of MEK1/2- and MKK3/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox tapeworm Echinococcus multilocularis.
Gelmedin V; Spiliotis M; Brehm K
Int J Parasitol; 2010 Apr; 40(5):555-67. PubMed ID: 19887070
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and in Vivo Effect of MAPK Signal Transduction Pathway Inhibitors on Echinococcus multilocularis.
Gui WF; Xu S; Dang ZS; Zhao YM
J Parasitol; 2019 Feb; 105(1):146-154. PubMed ID: 30807708
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae.
Hemer S; Brehm K
Int J Antimicrob Agents; 2012 Nov; 40(5):458-62. PubMed ID: 22947125
[TBL] [Abstract][Full Text] [Related]
5. Molecular Cloning and Characterization of a P38-Like Mitogen-Activated Protein Kinase from
Lü G; Li J; Zhang C; Li L; Bi X; Li C; Fan J; Lu X; Vuitton DA; Wen H; Lin R
Korean J Parasitol; 2016 Dec; 54(6):759-768. PubMed ID: 28095661
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of EmMPK1, an ERK-like MAP kinase from Echinococcus multilocularis which is activated in response to human epidermal growth factor.
Spiliotis M; Konrad C; Gelmedin V; Tappe D; Brückner S; Mösch HU; Brehm K
Int J Parasitol; 2006 Sep; 36(10-11):1097-112. PubMed ID: 16793045
[TBL] [Abstract][Full Text] [Related]
7. Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
Munoz L; Ramsay EE; Manetsch M; Ge Q; Peifer C; Laufer S; Ammit AJ
Eur J Pharmacol; 2010 Jun; 635(1-3):212-8. PubMed ID: 20226180
[TBL] [Abstract][Full Text] [Related]
8. Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1.
Schubert A; Koziol U; Cailliau K; Vanderstraete M; Dissous C; Brehm K
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2870. PubMed ID: 24901228
[TBL] [Abstract][Full Text] [Related]
9. A MEKK1 - JNK mitogen activated kinase (MAPK) cascade module is active in Echinococcus multilocularis stem cells.
Stoll K; Bergmann M; Spiliotis M; Brehm K
PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010027. PubMed ID: 34879059
[TBL] [Abstract][Full Text] [Related]
10. Impairing the maintenance of germinative cells in Echinococcus multilocularis by targeting Aurora kinase.
Cheng Z; Liu F; Tian H; Xu Z; Chai X; Luo D; Wang Y
PLoS Negl Trop Dis; 2019 May; 13(5):e0007425. PubMed ID: 31095613
[TBL] [Abstract][Full Text] [Related]
11. The role of fibroblast growth factor signalling in Echinococcus multilocularis development and host-parasite interaction.
Förster S; Koziol U; Schäfer T; Duvoisin R; Cailliau K; Vanderstraete M; Dissous C; Brehm K
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0006959. PubMed ID: 30849083
[TBL] [Abstract][Full Text] [Related]
12. Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development.
Hemer S; Konrad C; Spiliotis M; Koziol U; Schaack D; Förster S; Gelmedin V; Stadelmann B; Dandekar T; Hemphill A; Brehm K
BMC Biol; 2014 Jan; 12():5. PubMed ID: 24468049
[TBL] [Abstract][Full Text] [Related]
13. Components of the mitogen-activated protein kinase cascade are activated in hepatic cells by Echinococcus multilocularis metacestode.
Lin RY; Wang JH; Lu XM; Zhou XT; Mantion G; Wen H; Vuitton DA; Richert L
World J Gastroenterol; 2009 May; 15(17):2116-24. PubMed ID: 19418584
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of Ras- and Raf-homologues from the fox-tapeworm Echinococcus multilocularis.
Spiliotis M; Tappe D; Brückner S; Mösch HU; Brehm K
Mol Biochem Parasitol; 2005 Feb; 139(2):225-37. PubMed ID: 15664657
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor.
Kammerer B; Scheible H; Albrecht W; Gleiter CH; Laufer S
Drug Metab Dispos; 2007 Jun; 35(6):875-83. PubMed ID: 17344341
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
Koch DA; Silva RB; de Souza AH; Leite CE; Nicoletti NF; Campos MM; Laufer S; Morrone FB
Rheumatology (Oxford); 2014 Mar; 53(3):425-32. PubMed ID: 24241037
[TBL] [Abstract][Full Text] [Related]
17. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model.
Joekel DE; Lundström-Stadelmann B; Müllhaupt B; Hemphill A; Deplazes P
Exp Parasitol; 2018 May; 188():65-72. PubMed ID: 29625098
[TBL] [Abstract][Full Text] [Related]
19. p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells.
Corrèze C; Blondeau JP; Pomérance M
Eur J Endocrinol; 2005 Jul; 153(1):123-33. PubMed ID: 15994754
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
